Statistics
Publications
1
Citations
16
H-Index
1
Active since
2022
Affiliations
Eureka Therapeutics (United States)(Current)
Duo Yu is an author at Eureka Therapeutics (United States) specializing in t-cell malignancy therapy, cd19-directed bispecific antibodies, and relapsed diffuse large b-cell lymphoma.
Publications per year
2022–2022
1
1
1–1 of 1